About 30% of patients with cirrhosis have diabetes mellitus (DM). Nowadays, it is a matter for
debate whether type 2 DM in the absence of obesity and hypertriglyceridemia may be a risk …

The hepatitis C virus (HCV) is a major cause of chronic hepatitis, cirrhosis and
hepatocellular carcinoma worldwide. A significant portion of the morbidity and mortality …

Hepatitis C virus (HCV) infection is a systemic disease that is implicated in multiple
extrahepatic organ dysfunction contributing to its protean manifestations. HCV is associated …

Aim To assess the effect of hepatitis C virus (HCV) eradication on type 2 diabetes mellitus
(T2DM). incidence. Methods A prospective multicentre case–control study was performed …

Diabetes and hepatitis C infection are both prevalent diseases worldwide, and are
associated with increased morbidity and mortality. Most studies, but not all, have shown that …

Given the pandemic spread of the hepatitis C virus (HCV) infection and the metabolic
syndrome (MS), the burden of their interaction is a major public health issue, bound to …

In addition to causing cirrhosis and hepatocellular carcinoma, hepatitis C virus (HCV) is
thought to cause hypolipidemia, hepatic steatosis, insulin resistance, metabolic syndrome …

AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …

In addition to its effects in the liver, chronic hepatitis C virus (HCV) infection can have serious
consequences for other organ systems. Extrahepatic manifestations include mixed …

Abstract Type 1 diabetes (T1D) is due to antigen-specific assaults on the insulin producing
pancreatic β-cells by diabetogenic T-helper (Th) 1 cells.(CXC motif) ligand (CXCL) 10, an …